Abstract
Objective
This report presents the essence in practice of Japanese methods and tradition in surgery for esophageal cancer.
Methods
The etiology of esophageal cancer and the concepts of lymphadenectomy in esophagectomy, in neoadjuvant treatments, and in stage classifications are compared between Western countries and Japan.
Results
With respect to the type and relative incidence of esophageal cancer, in Western countries, adenocarcinoma in the lower thoracic esophagus and in the cardia is common, and among esophageal surgeons, there remains some controversy over the extent of lymphadenectomy. On the other hand, in Japan, squamous cell carcinoma in the middle thoracic esophagus is common, and concerning lymphadenectomy, Japanese esophageal surgeons consider that three-field lymphadenectomy is superior to other types of lymphadenectomy. In Japan, surgeons believe that most patients with esophageal cancer even those having lymph node metastasis can be best treated using esophagectomy and lymphadenectomy.
Conclusions
In Japan, the tradition in esophageal surgery places great significance on lymphadenectomy. The ways and procedures for esophageal cancer surgery, the neoadjuvant and adjuvant treatments, the Japanese Classification of Esophageal Cancer, the Esophageal Cancer Practice Guidelines, and other scientific reports are all based on a close combination of esophagectomy with lymphadenectomy.
Similar content being viewed by others
References
Torek F. The first successful case of resection of the thoracic portion of the oesophagus for carcinoma. Surg Gynecol Obstet. 1913;16:614–7.
Miyake H. Cases underwent surgery of the esophagus. Nippon Geka Gakkai Zasshi (J Jpn Surg Soc). 1925;26:197–9 (in Japanese).
Nakayama K. Carcinoma of the esophagus and the cardia: experience in approximately 3,000 cases. J Int Coll Surg. 1961;35:143–53.
Wong MCS, Hamilton W, Whiteman DC, Jiang JY, Qiao Y, Fung FDH, et al. Grobal incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries. Sci Rep. 2018;8:4522.
Cuesta MA, van der Peet D, Gisbertz SS, Straatman J. Mediastinal lymphadenectomy for esophageal cancer: difference between two countries, Japan and the Netherlands. Ann Gastroenterol Surge. 2018;2:176–81.
Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, et al. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: parts 1 and 2. Esophagus. 2019;16:1–43.
Harrison LE. Is esophageal cancer a surgical disease? J Surg Oncol. 2000;75:227–31.
Theories on the national history of breast cancer. https://pages.uoregon.edu/jbonine/rad02.html. Accessed 15 Nov 1996.
Seo S. Esophageal surgery. Nippon Geka Gakkai Zasshi (J Jpn Surg Assoc). 1933;33:1461–505 (in Japanese).
Ohsawa T. Esophageal surgery. Nippon Geka Gakkai Zasshi (J Jpn Surg Assoc). 1933;34:1319–590 (in Japanese).
Japanese Research Society for Gastric Cancer. Proposal of general rules for the gastric cancer study. 1st ed. Tokyo: Japanese Research Society for Gastric Cancer; 1962 (in Japanese).
Japanese Society of Esophageal Diseases. Esophageal cancer - Esophageal cancer - Descriptive rules in clinic and pathology. 1st ed. Tokyo: Japanese Society of Esophageal Diseases; 1969 (in Japanese).
Fujita H, Sueyoshi S, Tanaka T, Fujii T, Toh U, Mine T, et al. Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: the short- and long-term outcome among the four types of lymphadenectomy. World J Surg. 2003;27:571–9.
Lewis I. The surgical treatment of carcinoma of the oesophagus with specific reference to a new operation for growths of the middle third. Br J Surg. 1946;34:18–311.
Logan A. The surgical treatment of carcinoma of the esophagus and cardia. J Thorac Cardiovasc Surg. 1963;46:150–61.
Siewert JR, Hölscher AH. Eingriffe beim Ösophaguskarzinom. In: Siewert JR, editor. Breitner Chirurgische Operationslehre Band IV, Chirurgie des Abdomens 2 Ösophagus, Magen und Duodenum. Baltimore: Urban & Schwarzenberg; 1989. p. 17–54.
Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology. 1991;48:411–20.
Fujita H, Kakegawa T, Yamana H, Holscher AH, Bollschweiler E. Siewert JR. The results of the en bloc esophagectomy compared with three-field and two-field dissection. In: Nabeya K, Hanaoka T, Nogami H, editors. Recent Advances in Diseases of the Esophagus. Tokyo: Springer-Verlag; 1993. p. 703–708.
Orringer MB. Technical aids in performing transhiatal esophagectomy without thoracotomy. Ann Thorac Surg. 1984;38:128–31.
Omloo JMT, Lagarde SM, Hulscher JBF, Reitsma JB, Fockens P, van Dekken H, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus—five-year survival of a randomized clinical trial. Ann Surg. 2007;246:992–1001.
Smith BR, Hinojosa MW, Reavis KM, Nguyen NT. Outcomes of esophagectomy according to surgeon’s training: general vs. thoracic. J Gastrointest Surg. 2008;12:1907–11.
Fujita H. The history of lymphadenectomy for esophageal cancer and the future prospects for esophageal cancer surgery. Surg Today. 2015;45:140–9.
Cuschieri A, Shimi S, Banting S. Endoscopic esophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb. 1992;37:7–11.
Akaishi T, Kaneda I, Higuchi N, Kuriya Y, Kuramoto J, Toyoda T, et al. Thoracoscopic en bloc total esophagectomy with radical mediastinal lymphadenectomy. J Thorac Cardiovasc Surg. 1996;112:1533–41.
National cancer Institute. Esophageal cancer treatment (adult) (PDQ®)—Health professional version—https://www.cancer.gov/types/rsophageal/hp/esophageal-treatment-pdq. Accessed 22 Jan 2020.
van Hagen P, Hulsher MC, van Lanschot JJ, Steyerberg EW, van Berg Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–84.
Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.
International Union Against Cancer. Oesophagus (ICD-0 150). In: Harmer MH, editor. TNM classification of malignant tumours. 3rd ed. Geneva: International Union Against Cancer; 1978. p. 57–62.
International Union Against Cancer. Oesophagus (ICD-0 C15) including oesophagogastric junction (C16.0). In: Sobin LH, Gospodarowicz MK, Wittekind Ch, editors. TNM classification of malignant tumours. 7th ed. Hoboken: Oxford: Wiley-Blackwell; 2019. p. 66–72.
Japanese Society of Esophageal Diseases. Esophageal cancer—descriptive rules in clinic and pathology. 2nd ed. Tokyo: Kanehara; 1972 (in Japanese).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fujita, H. Ways and tradition of Japan in esophageal surgery for cancer. Gen Thorac Cardiovasc Surg 68, 1187–1192 (2020). https://doi.org/10.1007/s11748-020-01369-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-020-01369-4